Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Akiko Yashima-Abo"'
Autor:
Tsuyoshi Sato, Takahiro Maeta, Ryosuke Abe, Hiroyuki Yamada, Kazuyuki Ishida, Akiko Yashima-Abo, Kazuki Kiyohara, Shinri Miyajima, Shigeki Ito
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 343-346 (2021)
Salivary duct carcinoma (SDC) is a rare and highly aggressive malignancy. A 58-year-old man presented with a right-sided submandibular mass and metastatic lesions in the right supraclavicular and inferior internal jugular nodes. He underwent right su
Externí odkaz:
https://doaj.org/article/387282b23046402cb5752b84281c2e73
Autor:
Kanki Otsuka, Mizunori Yaegashi, Hayato Hiraki, Akiko Yashima-Abo, Takeshi Iwaya, Nishizuka, Satoshi S., Akira Sasaki
Publikováno v:
Journal of Iwate Medical Association; Apr2024, Vol. 76 Issue 1, p9-20, 12p
Autor:
Tomoko Sasaki, Takeshi Iwaya, Mizunori Yaegashi, Masashi Idogawa, Hayato Hiraki, Masakazu Abe, Yuka Koizumi, Noriyuki Sasaki, Akiko Yashima-Abo, Ryosuke Fujisawa, Fumitaka Endo, Shoichiro Tange, Tomomi Hirano, Koki Otsuka, Akira Sasaki, Mari Masuda, Masashi Fujita, Hidewaki Nakagawa, Fumiaki Takahashi, Yasushi Sasaki, Takashi Tokino, Satoshi S. Nishizuka
BACKGROUND & AIMSThis study investigated whether a circulating tumor DNA (ctDNA) assay using digital PCR (dPCR) could provide early relapse detection and disease-free corroboration at molecular level during postoperative surveillance of colorectal ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c76e34ad7dba5e31d0256c387d748ed
https://doi.org/10.1101/2022.09.03.22279571
https://doi.org/10.1101/2022.09.03.22279571
Publikováno v:
Cancer Research. 83:6704-6704
Background: Circulating tumor DNA (ctDNA), a new class of tumor marker, has been demonstrated the clinical validity of: 1) early relapse prediction, 2) therapeutic efficacy evaluation, and 3) relapse-free corroboration in the context of cancer treatm
Publikováno v:
Cancer Research. 83:5599-5599
Background: Many patients undergo a next generation sequencing (NGS)-based cancer genome profiling (CGP) test, but it often does not aid in choosing an optimal therapeutic regimen. Therefore, the genomic information should be used for minimal residua
Autor:
Shigeki Ito, Ryosuke Abe, Kazuki Kiyohara, Akiko Yashima-Abo, Hiroyuki Yamada, Shinri Miyajima, Tsuyoshi Sato, Takahiro Maeta, Kazuyuki Ishida
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 343-346 (2021)
Case Reports in Oncology
Case Reports in Oncology
Salivary duct carcinoma (SDC) is a rare and highly aggressive malignancy. A 58-year-old man presented with a right-sided submandibular mass and metastatic lesions in the right supraclavicular and inferior internal jugular nodes. He underwent right su
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
The antigenic heterogeneity of the reticular framework of the white pulp and marginal zone is well documented in the human adult spleen. Immunostaining of α-smooth muscle actin characterizes the heterogeneity of the reticular framework of the white
Autor:
Yuka Koizumi, Tamotsu Sugai, Fumiaki Takahashi, Lance A. Liotta, Satoshi Nishizuka, Ginny Espina, Miyuki Ikeda, Ryo Sugimoto, Keisuke Koeda, Takeshi Iwaya, Akiko Yashima-Abo, Sheny Ahmad
BackgroundParadoxically,Helicobacter pylori-positive (HP+) advanced gastric cancer patients have a better prognosis than those who are HP-negative (HP-). Immunologic and statistical analyses can be used to verify whether systematic mechanisms modulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de3e15f6589b9746c1e29e3fe91d65b5
https://doi.org/10.1101/2021.09.24.21263620
https://doi.org/10.1101/2021.09.24.21263620
Autor:
Yuka, Koizumi, Sheny, Ahmad, Miyuki, Ikeda, Akiko, Yashima-Abo, Ginny, Espina, Ryo, Sugimoto, Tamotsu, Sugai, Takeshi, Iwaya, Gen, Tamura, Keisuke, Koeda, Lance A, Liotta, Fumiaki, Takahashi, Satoshi S, Nishizuka
Publikováno v:
J Natl Cancer Inst
Background Paradoxically, Helicobacter pylori–positive (HP+) advanced gastric cancer patients have a better prognosis than those who are HP–negative (HP-). Immunologic and statistical analyses can be used to verify whether systemic mechanisms mod
Autor:
Naoki Yanagawa, Masao Nishiya, Noriyuki Yamada, Shigeki Ito, Noriyuki Uesugi, Akiko Yashima-Abo, Natsuki Sasaki, Tamotsu Sugai, Inako Kikuchi, Mitsumasa Osakabe, Kazuyuki Ishida, Kazuki Kiyohara, Junichi Ambo
Publikováno v:
Diagnostic Cytopathology. 49:168-170